Mobile Apps

The ACC has partnered with various organizations to create a variety of resources optimized for smart phones and tablets. These apps fall into three categories: Clinical, Cardiovascular Publications, and Member Engagement.

Clinical

ACCSAP 8

The ASCVD Risk Estimator is published jointly by the American College of Cardiology (ACC) and the American Heart Association (AHA) to help health care providers and patients estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD) using the Pooled Cohort Equations and lifetime risk prediction tools. This app is intended as a companion tool to the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

The ASCVD Risk Estimator provides easy access to recommendations specific to calculated risk estimates. Additionally, the app includes readily accessible guideline reference information for both providers and patients related to therapy, monitoring, and lifestyle. Find out more >>>

AnticoagEvaluator

The AnticoagEvaluator helps clinicians make well-informed decisions on antithrombotic therapy for their non-valvular AF patients. Use this app to:

  • Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
  • Review Guideline-driven therapy guidance for stroke prevention
  • Generate individualized risk for antithrombotic therapy options based on individual clinical trials
  • Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics

The AnticoagEvaluator is available on the web, and all Apple and Android phones and tablets." Find out more >>>

Download on the App Store Get it on Google Play
BridgeAnticoag app

New! The BridgeAnticoag app supports clinicians across specialties in safely managing anticoagulation around an invasive procedure for NVAF patients. The app calculates patient and procedural risk to provide individualized advice that balances bleed and stroke risk.

Use the app to assess whether and how to:

  • Interrupt anticoagulation
  • Bridge anticoagulation
  • Restart anticoagulation

Email yourself a detailed report of the app assessment.

The BridgeAnticoag app is available on the web, and all Apple and Android phones and tablets." Find out more >>>

Download on the App Store Get it on Google Play
CardioSmart Explorer

The ACC’s CardioSmart Heart Explorer App has been revamped with the goal of furthering the clinician/patient relationship at the point of care. Newly enhanced high-resolution cardiac graphics and animations are designed to help effectively review and discuss common heart problems and treatment options with patients. New to the app, heart failure and atrial fibrillation information can be emailed directly to patients through the app. The app is now available for use on both iPads and iPhones, with an Android version coming soon. Log-in information is no longer required. Download the app for free via the iTunes store. Find out more at CardioSmart.org/Explorer.

Download on the App Store
ACC CathPCI Bleeding Risk Calculator App

The ACC CathPCI Bleeding Risk Calculator App helps clinicians assess the individualized patient risk of experiencing a bleeding event associated with a PCI procedure. Clinicians can compare individual patient risk to the national average based on data from the CathPCI Registry®. The App facilitates consistent risk assessment and communication between a clinician and patient about the overall PCI procedure. Find out more >>>

Download on the App Store Get it on Google Play
DAPT Risk Calculator

The ACC DAPT Risk Calculator App provides decision support for clinicians evaluating the continuation of DAPT therapy for patients at least 12 months post-PCI procedure, and the risk/benefit of continuing or discontinuing DAPT. The App provides a DAPT Risk Score as a numerical value between -2 and +9, where higher DAPT scores suggest that the benefit/risk ratio with prolonged DAPT may be favorable. Conversely, lower DAPT scores suggest that the benefit/risk ratio with prolonged DAPT is NOT favorable. It also calculates the percentage of risk for three end points: myocardial infarction (MI), stent thrombosis, major adverse cardiovascular and cerebrovascular events (MACCE), and bleeding.

The DAPT Risk Calculator is currently available in App Store and on Google Play. Find out more >>>

Download on the App Store Get it on Google Play
Focus App

The FOCUS App is a decision support tool for clinicians that helps guide and improve appropriate ordering of cardiovascular imaging and tests. The app provides official ACC Appropriate Use Criteria (AUC) ratings and decision algorithms for SPECT MPI, PET, stress echo and CTA to drive clinical decision making for your patient. It automatically calculates risk and pretest probability based on the patient's age, gender and clinical risk factors to derive accurate AUC ratings. The app is currently available for use on iPad.

Download on the App Store
Guideline App

The ACC's Guideline Clinical App is the mobile home of clinical guideline content and tools for clinicians caring for patients with cardiovascular disease. You can access guideline recommendations, "10 Points" summaries, and tools such as risk scores, calculators and algorithms. Customize your App by using the bookmark, note-taking, and shareable PDF features. Find out more >>>

Download on the App Store Get it on Google Play
ICD/CRT Appropriate Use Criteria App

The ICD/CRT Appropriate Use Criteria App provides decision and documentation support for clinicians assessing the suitability of ICD implantation and CRT. After selecting ICD or CRT as the intended therapy, clinicians will enter a patient’s LVEF and NYHA class to:

  • Obtain an appropriate use rating for ICD/CRT
  • View the likelihood of CMS coverage for the patient receiving an ICD
  • Produce a summary of patient inputs and advice for email.

Find out more >>>

Download on the App Store Get it on Google Play
ICD/CRT Appropriate Use Criteria App

LDL-C Manager helps clinicians reduce ASCVD risk by managing LDL-C. The app guides clinicians through one continuous lipid-lowering process by linking the ASCVD Risk Estimator, Statin Intolerance app, and the brand new Lipid-Lowering Therapy tool based on the 2016 Role of Non-Statin Therapies Expert Consensus Decision Pathway.

Input individualized patient data to:

  • Estimate ASCVD risk
  • Review customized lifestyle and statin initiation advice
  • Assess patient-specific response to lipid-lowering therapy
  • Determine when and which non-statin therapies should be considered

Email yourself a detailed report of all assessments conducted within the app.

Find out more >>>

Download on the App Store Get it on Google Play
Statin App

The NCDR Clinical Quality Coach provides physicians with a convenient mobile solution for documenting and tracking their clinical practice improvement activities. Leveraging National Cardiovascular Data Registry data, physicians are able to access and track quality performance metrics and use their data to inform quality improvement efforts. Currently available for physicians participating in the CathPCI Registry® – other NCDR registries will be added soon. The NCDR Clinical Quality Coach also provides physicians with an easy and streamlined way to submit documentation of their clinical practice improvement activities for American Board of Medical Specialties (ABMS) credit. Find out more >>>

Download on the App Store Get it on Google Play
Statin App

The ACC Statin Intolerance App guides clinicians through the process of managing and treating patients who report muscle symptoms while on statin therapy. Clinicians can use the app to evaluate possible intolerance to a patient’s current statin prescription, follow steps to manage and treat a patient who reports muscle symptoms on a statin, and compare statin characteristics and drug interactions to inform management of LDL-related risk. Information in the app is derived from ACC/AHA cholesterol guidelines and best practices. Find out more >>>

Download on the App Store Get it on Google Play
TAVR App

The STS/ACC TAVR In-Hospital Mortality Risk App assists clinicians in determining the predicted in-hospital mortality risk of a patient who is considering TAVR as a treatment option for AVR. Clinicians can evaluate a patient’s mortality risk and compare it to the national average based on STS/ACC TVT Registry data. Find out more >>>

Download on the App Store Get it on Google Play

Cardiovascular Publications

ACCEL

Subscribers to ACCEL can search for and retrieve interviews from the popular audio journal online. This area features MP3 files that are easily searchable and downloadable to your computer and MP3 player.

Find out more >>>

JACC Journals App

The latest research and clinical practice updates in cardiology are at your fingertips with the JACC Journals app. Now you can read the entire family of journals from the ACC in a single app, across all IOS and Android devices. You can: browse new issues; jump to featured articles; interact with figures, tables and multimedia content; personalize your experience with My Reading List; save articles for offline reading; share articles via social media; email useful content; and much more!

Download on the App Store Get it on Google Play

Member Engagement

ACC Advocacy Action

ACC members can engage with lawmakers and influence health policy with the ACC Advocacy Action mobile app. The app includes an interactive congressional directory to locate lawmakers, timely talking points to share during congressional visits, an event scheduler to keep track of Capitol Hill meetings, social media tools to engage with legislators, and more.

Download on the App Store Get it on Google Play
ACC Connect

Available exclusively to ACC members, ACC Connect delivers a convenient mobile application with several modules to help members connect, as well as interact and engage with their colleagues, peers and the College. ACC Connect also allows members to search the member directory and update their profile and get the latest ACC news. Compatible with iPhone, iPod Touch, and iPad. Requires iOS 3.0 or later.

Download on the App Store